Less Than Half Of Patients Who Are Positive For High-Risk HPV With Negative Cytologic Findings Are Retested During Guideline-Recommended Time Frame, Study Finds

MedPage Today (1/17, Robertson) reported, “Less than half of patients who were positive for high-risk human papillomavirus (HPV) with negative cytologic findings were retested during the guideline-recommended time frame, a cohort study showed.” Researchers found that “during the first 16 months after an index positive HPV result, only 43.7% of patients received an initial surveillance test, of whom 18.2% had HPV-negative results and negative intraepithelial lesion or malignancy cytologic findings and 25.5% had abnormal results.” The findings were published in JAMA Network Open.